Solvay Increases Specialty Polymers Production Capacity by 70% in India

Solvay announced today a capacity increase of 70% at its Panoli plant, India, for the production of its high performance polymers KetaSpire polyetheretherketone (PEEK) and AvaSpire polyaryletherketones (PAEK).

Panoli is Solvay's largest plant worldwide for these two ultra performance polymers. Nearly half of this capacity increase has already been implemented and successfully brought on-line. The second phase of the project will be completed by mid 2013 and will allow the plant to continue to satisfy growth in demand.

With this investment, the Group reaches a new milestone in realizing its ambition to double its sales in India by 2015. Last week Solvay announced it is acquiring a controlling stake in Sunshield Chemicals, an Indian company specializing in surfactants, and some months ago it opened a major innovation centre in Savli (Gujarat State). The Group has been doing business in India since 2000 through its Novecare, Engineering Plastics and Specialty Polymers activities. With seven production sites and about 900 employees, the Group generated net sales of €180 million in India in 2011.

 

 

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.